16-2830430-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145252.3(ZG16B):c.-12C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000767 in 1,603,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145252.3 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZG16B | NM_145252.3 | c.-12C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 4 | ENST00000382280.8 | NP_660295.3 | ||
ZG16B | NM_145252.3 | c.-12C>T | 5_prime_UTR_variant | Exon 2 of 4 | ENST00000382280.8 | NP_660295.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZG16B | ENST00000382280 | c.-12C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 4 | 1 | NM_145252.3 | ENSP00000371715.4 | |||
ZG16B | ENST00000382280 | c.-12C>T | 5_prime_UTR_variant | Exon 2 of 4 | 1 | NM_145252.3 | ENSP00000371715.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152152Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000265 AC: 6AN: 226436Hom.: 0 AF XY: 0.0000162 AC XY: 2AN XY: 123390
GnomAD4 exome AF: 0.0000820 AC: 119AN: 1450918Hom.: 0 Cov.: 32 AF XY: 0.0000791 AC XY: 57AN XY: 721062
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152152Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.97C>T (p.R33W) alteration is located in exon 2 (coding exon 2) of the ZG16B gene. This alteration results from a C to T substitution at nucleotide position 97, causing the arginine (R) at amino acid position 33 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at